Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex ER vs Quetiapine for Behavioral Symptoms in Alzheimer's Dementia
NCT00375557Phase 4Withdrawn
- Sponsor
- University of Cincinnati
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of divalproex sodium in Alzheimer's disease (AD), sponsored by University of Cincinnati. Planned start Oct 2006; status: withdrawn.
02
Drugs
divalproex sodium
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00375557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375557.